Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Jasper Therapeutics, Inc.Listing on record | Buy | $4.5M | conv 60ClusterFirst in 12mo | SEC | |
Jasper Therapeutics, Inc.Listing on record | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
Jasper Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Jasper Therapeutics, Inc.Listing on record | ExerciseD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Jasper Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROGENICS PHARMACEUTICALS INCListing unverified | Buy | $563.9K | conv 35First in 12mo | SEC | |
PROGENICS PHARMACEUTICALS INCListing unverified | Buy | $314.9K | conv 1 | SEC | |
Horizon Therapeutics Public Ltd CoListing unverified | Sell | $70.2M | SEC |